Fennec Pharmaceuticals (FENC) Treasury Shares (2021 - 2026)
Fennec Pharmaceuticals' (FENC) quarterly Treasury Shares came in at $314000.0 in Q4 2025, down 3.09% YoY from $324000.0 in Q4 2024, and down 25.06% on a QoQ basis from $419000.0 in Q3 2025.
Fennec Pharmaceuticals (FENC) Treasury Shares (2021 - 2026) Analysis & Trends
Fennec Pharmaceuticals (FENC) has 5 years of Treasury Shares data on file, last reported at $314000.0 in Q4 2025.
- Quarterly Treasury Shares fell 3.09% year-over-year to $314000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $314000.0 (down 3.09% YoY) and the FY2025 annual result came in at $387000.0, up 19.44% from the prior year.
- Treasury Shares retreated to $314000.0 in Q4 2025, from $419000.0 in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $589000.0 in Q1 2025 to a low of $35000.0 in Q4 2022.
- A 5-year average of $244473.7 and a median of $219000.0 in 2021 frame the typical range for Treasury Shares.
- Annual changes were most pronounced in 2022 — Treasury Shares slumped 84.02% — and 2023, when it jumped 522.86%.
- Tracing FENC's Treasury Shares over 5 years: stood at $219000.0 in 2021, then tumbled by 84.02% to $35000.0 in 2022, then jumped by 522.86% to $218000.0 in 2023, then jumped by 48.62% to $324000.0 in 2024, then retreated by 3.09% to $314000.0 in 2025.
- The last three Treasury Shares figures came in at $314000.0 (Q4 2025), $419000.0 (Q3 2025), and $100000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.08 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.72 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 92,219.00 |
| 10 | Fennec Pharmaceuticals | 410.60 Mn | 369.35 Mn | 17.15 Mn | 217,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 217,000.00 |
| Jun 30, 2026 | 217,000.00 |
| Dec 31, 2025 | 314,000.00 |
| Dec 31, 2025 | 314,000.00 |
| Sep 30, 2025 | 419,000.00 |
| Sep 30, 2025 | 419,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Mar 31, 2025 | 589,000.00 |
| Mar 31, 2025 | 589,000.00 |
| Dec 31, 2024 | 324,000.00 |
| Dec 31, 2024 | 324,000.00 |
| Sep 30, 2024 | 367,000.00 |
| Sep 30, 2024 | 367,000.00 |
| Jun 30, 2024 | 445,000.00 |
| Jun 30, 2024 | 445,000.00 |
| Mar 31, 2024 | 214,000.00 |
| Mar 31, 2024 | 214,000.00 |
| Dec 31, 2023 | 218,000.00 |
| Dec 31, 2023 | 218,000.00 |